Catalyst Pharmaceuticals

CPRX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Product Revenue Growth YoY

7.5%

FIRDAPSE Revenue Growth YoY

18.3%

AGAMREE Revenue Growth YoY

Loading...

Catalyst Pharmaceuticals

Unlock previous datapoints

Upgrade

Catalyst Pharmaceuticals

Unlock previous datapoints

Upgrade

Catalyst Pharmaceuticals Revenue by Segment

Revenue by Segment

FIRDAPSE Revenue

CapyFin.com

AGAMREE Revenue

CapyFin.com

FYCOMPA Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.05B

P/E Ratio

8.93

Sector

N/A

Industry

N/A

52-Week High

$26.3

52-Week Low

$19.1

Product Revenue Growth YoY

7.5%

FIRDAPSE Revenue Growth YoY

18.3%

AGAMREE Revenue Growth YoY

67.5%

GAAP Net Income Growth YoY

-5.8%

Operating Income Growth YoY

-1.6%

Products

Get in Touch

Resources

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Revenue by Segment

Revenue by Segment

FIRDAPSE Revenue

AGAMREE Revenue

FYCOMPA Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics